This sector has been back in vogue, but investors could miss out on further upside without careful stock selection.
Halliburton is downgraded to 'underweight,' and Eli Lilly is initiated with a 'buy.'
Exelon is downgraded to 'hold,' and Jabil Circuit is initiated with a 'buy.'
A string of serious setbacks for possible treatments may be eroding researchers' -- and investors' -- confidence.
Unlike biotechs, many of these companies are pouring money into share buybacks -- instead of their long-term pipelines.
The only explanation for recent stock action is market players following others blindly. The bulls just have to hope analysts don't think this is National Lemming Week.
Investors are digesting a slew of earnings as they await jobless claims data.
VIDEO ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Tying the knot doesn't mean your credit will follow suit. Take a look at these common credit myths about marriage.
In a tax case, a US judge ruled that the agency's published guidelines don't hold up in court.
MUST-SEE ON MSN
- Video: Easy DIY smoked meats at home
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'